Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Halogenated hydrocarbon doai
Patent
1995-06-07
1998-03-10
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Halogenated hydrocarbon doai
514759, 424718, A61K 3102, A61K 3300
Patent
active
057262098
ABSTRACT:
Biocompatible fluorocarbon emulsions are utilized to inhibit the removal of endogenously produced nitric oxide from the bloodstream, and to thereby inhibit vascular stenosis, vasoconstriction, and any other physiological condition or disorder arising in whole or in part from a deficiency of endogenous nitric oxide.
REFERENCES:
patent: 4781676 (1988-11-01), Schweighardt et al.
patent: 4865836 (1989-09-01), Long
patent: 4866096 (1989-09-01), Schweighardt
patent: 4895876 (1990-01-01), Schweighardt et al.
patent: 4927623 (1990-05-01), Long
patent: 4987154 (1991-01-01), Long
patent: 4993415 (1991-02-01), Long
Buddemeier, et al. "Oxygent.RTM. (Oxygen-Carrying Perfluorochemical Emulsion) Preserves Endothelial Dependent and Independent Vasodilator Responses After Experimental Myocardial Infarction and Reperfusion" Clinical Research Meeting Apr. 29-May 2, 1994.
Carter, et al. "Nitric Oxide Production is Intensely and Persistently Increased in Tissue by Thermal Injury" Biochem. J. 304: 201-204 (1994).
Kovach, et al. "Endothelial Dysfunction in Shock States" Am. Physiol. Soc. 8: 145-148 (1993).
Kovach, et al. "Effects of N.sup.G -Nitro-L-Arginine and L-Arginine on Regional Cerebral Blood Flow in the Cat" J. of Physiology 449: 183-196 (1992).
Lefer, et al. "Microvascular Actions of Nitric Oxide Donors in Circulatory Disorders" Nitric Oxide Conference, Mar. 27-28, 1995 (8 pgs.).
Lefer, et al. "Antineutrophil and Myocardial Protecting Actions of a Novel Nitric Oxide Donor After Acute Myocardial Ischemia and Reperfusion in Dogs" Circulation 88(5 Part 1): 2337-2350 (1993).
Milner, Anthony D. "Nitric Oxide" Eur. J. Pediatr. 153 (Suppl 2): S7-S11 (1994).
"Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome" New England J. of Medicine 329(3): 206-207 (1993).
Pinsky, et al. "The Role of Nitric Oxide in Cardiac Preservation for Transplantation" Circulation 88(4 Part 2): (1993).
Roberts, et al. "Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn" The Lancet 340:818-819 (1992).
Rubanyi, Gabor M. "The Role of Endothelium in Cardiovascular Homeostasis and Diseases" J. of Cardiovascular Pharmacology 22 (Suppl 4): S1-S14 (1993).
Rubanyi, et al. "Cytoprotective Function of Nitric Oxide: Inactivation of Superoxide Radicals Produced by Human Leukocytes" Biochem. and Biophys. Res. Commun. 181(3): 1392-1397 (1991).
Suzuki, et al. "Hemoglobin Augmentation of Interleukin-1.beta.-Induced Production of Nitric Oxide in Smooth-Muscle Cells" J. Neurosurg 81: 895-901 (1994).
"Perfluorochemical Blood Substitutes" Technical Information Ser. No. 5 (pp. 1-177) Jun. 30, 1978.
"Perfluorochemical Blood Substitutes" Technical Information Ser. No. 7 (pp. 1-119) Jul. 30, 1981.
Kinsella, et al. "Clinical Responses to Prolonged Treatment of Persistent Pulmonary Hypertension of the Newborn with Low Doses of Inhaled Nitric Oxide" J. of Pediatrics 123(1): 103-108 (1993).
Zayek, et al. "Treatment of Persistent Pulmonary Hypertension in the Newborn Lamb by Inhaled Nitric Oxide:" J. of Pediatrics 122(5 Part 1): 743-750 (1993).
Fazekas, et al. "Effect of Nitric Oxide Inhibition on Capsaicin-Elicited Vasodilation in the Rat Oral Circulation" Res. Esp. Med. 194: 357-365 (1994).
Leach et al, Pediatric Research, vol. 35, No. 4 Part 2, Apr. 1994, p. 394A, abstract No. 2351.
Flaim Stephen F.
Riess Jean G.
Alliance Pharmaceutical Corp.
Jarvis William R. A.
LandOfFree
Liquid fluorocarbon emulsion as a vascular nitric oxide reservoi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liquid fluorocarbon emulsion as a vascular nitric oxide reservoi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid fluorocarbon emulsion as a vascular nitric oxide reservoi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-140032